Eichinger Walter, Däbritz Sabine, Lange Rüdiger
Clinic for Thoracic and Cardiovascular Surgery, German Heart Center Munich, Lazarettstrasse 36, D-80636 Munich, Germany.
Eur J Cardiothorac Surg. 2007 Nov;32(5):690-5. doi: 10.1016/j.ejcts.2007.08.015. Epub 2007 Sep 17.
The approval of a heart valve for the European market takes place in accordance with European and international standards. A new version of the EN Standards was published in June 2006, which responded to different technical innovations in the area of heart valve technology. This work outlines the differences between the new EN ISO 5840 (2005) and the old EN 12006-1 (1999).
We compared the 'new' EN ISO 5840 (2005) and the 'old' EN 12006-1 (1999).
The following aspects have been updated in the new EN ISO 5840: Size designation of biological and mechanical heart valve prostheses in accordance with the patient annulus. Differentiation of the annular implantation position (intra-annular, intra-supra-annular, supra-annular). Table for the description of the components of a heart valve prosthesis. Use of compliance chambers for the hydrodynamic testing of prostheses without scaffold. Determination of the minimum requirement for heart valve prostheses in hydrodynamic tests and specification of reference values with regard to prosthesis-related complications in clinical studies. Definition of the requirements for clinical long-term studies (patient number, length). Introduction of an obligatory post-observation timeframe of 5 years for mechanical heart valves and of 10 years for biological heart valves.
The update in the new EN ISO 5840 gives consideration to the technologic evolution of heart valve development. Several changes in the new standard will improve safety for the patient and ensure high quality in the field of heart valve technology.
心脏瓣膜在欧洲市场的获批需符合欧洲和国际标准。EN标准的新版本于2006年6月发布,该版本回应了心脏瓣膜技术领域的不同技术创新。本研究概述了新的EN ISO 5840(2005)与旧的EN 12006-1(1999)之间的差异。
我们对比了“新的”EN ISO 5840(2005)和“旧的”EN 12006-1(1999)。
新的EN ISO 5840在以下方面进行了更新:根据患者瓣环对生物和机械心脏瓣膜假体进行尺寸标注。区分瓣环植入位置(瓣环内、瓣环上-瓣环内、瓣环上)。心脏瓣膜假体组件描述表。使用顺应性腔室对无支架假体进行流体动力学测试。确定心脏瓣膜假体在流体动力学测试中的最低要求,并规定临床研究中与假体相关并发症的参考值。定义临床长期研究的要求(患者数量、时长)。引入机械心脏瓣膜5年和生物心脏瓣膜10年的强制性观察后时间框架。
新的EN ISO 5840中的更新考虑了心脏瓣膜发展的技术演变。新标准中的多项变化将提高患者安全性,并确保心脏瓣膜技术领域的高质量。